Clearly the RAC posters are bored since they are still waiting for ethic approval for months. It might be worthwhile trading RAC as @johndprent think "FOMO" will somehow push the MC to $500M in the lead up of just starting clinical trial for RC220.
Add to My Watchlist
What is My Watchlist?